News
Hims & Hers, the high-flying online health company that rapidly grew from a buzzy startup selling Viagra to a ...
3d
Stocktwits on MSNHims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent ExpiresHims & Hers Health, Inc. (HIMS) announced on Wednesday that it will expand to Canada next year with its weight loss program, ...
3d
InvestorsHub on MSNHims & Hers Shares Gain on Plans for Canadian Launch Featuring Generic SemaglutideHims & Hers Health (NYSE:HIMS) shares climbed 2% on Wednesday following the announcement of its planned market entry into ...
Seeking Alpha's daily roundup of remarks and statements that could impact markets, sectors or individual stocks. Read more ...
StockStory.org on MSN3d
Hims & Hers Health (HIMS) Stock Is Up, What You Need To KnowShares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced ...
Hims & Hers Health reports 111% Q1 2025 revenue growth to $586M, driven by personalized treatments & strong margins. Read why ...
U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...
10don MSN
Hims & Hers Health (HIMS -3.91%) is a telehealth company that offers personalized solutions for its customers. And demand has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results